42 results on '"Hurle, Rodolfo"'
Search Results
2. A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer
3. Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
4. International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity
5. Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy.
6. Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomy.
7. Development of a microultrasound-based nomogram to predict extra-prostatic extension in patients with prostate cancer undergoing robot-assisted radical prostatectomy
8. Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database
9. MP56-06 NOVEL RENAL CELL CARCINOMA TNM STAGING CLASSIFICATION: WHERE DOES MICROWAVE ABLATION FINDS ITS INDICATION?
10. MP31-03 DECODING CLINICALLY SIGNIFICANT PROSTATE CANCER IN BIOPSY NAIVE PATIENTS: A MACHINE LEARNING APPROACH FROM A TERTIARY REFERRAL CENTER
11. PD13-12 DIAGNOSTIC PERFORMANCE OF MICROULTRASOUND AT CONFIRMATORY RECLASSIFICATION BIOPSY IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
12. MP71-12 EVALUATING THE OUTCOMES OF BLADDER-SPARING TREATMENTS (BST) IN PATIENTS WITH BCG-UNRESPONSIVE AND BCG-EXPOSED NMIBC
13. MP16-01 REPLACING RETUR WITH CYSTOSCOPY IN HIGH-GRADE T1 NMIBC PATIENTS: CONFIRMATORY RESULTS FROM THE HUNIRE TRIAL
14. PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION
15. PD30-06 PHOTODYNAMIC DIAGNOSIS (PDD) DIRECTED BIOPSIES VS WHITE LIGHT BLADDER MAPPING IN PATIENTS WITH POSITIVE CYTOLOGY AND NEGATIVE PREOPERATIVE WORKUP: AN INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY
16. MP49-15 EVALUATING THE ROLE OF PRI-MUS PROTOCOL IN IDENTIFYING CLINICALLY SIGNIFICANT PROSTATE CANCER: A HIGH-VOLUME EXPERIENCE ON MICROULTRASOUND
17. PD19-12 THE ROLE OF PSMA PET/CT IN PREDICTING PATHOLOGICAL LOCAL STAGING AND GRADING FOR PROSTATE CANCER
18. MP22-13 FRAILTY ADAPTED ERAS PATHWAY FOR PATIENTS WITH BLADDER CANCER REQUIRING SURGERY: THE GLOBAL RADICAL CYSTECTOMY EVALUATION AND MANAGEMENT (GRACEM) STUDY PROTOCOL
19. MP67-03 IMPACT OF NUMBER OF INNER AND OUTER RENORRAPHY STITCHES ON FUNCTIONAL OUTCOMES AFTER ROBOTIC ASSISTED PARTIAL NEPHRECTOMY
20. MP67-11 PREDICTIVE FACTORS OF 60 DAYS DISEASE PERSISTENCE AND 6-12 MONTHS RECURRENCE AFTER MICROWAVE ABLATION TREATMENT FOR SMALL RENAL MASSES: A SINGLE-CENTER INSTITUTIONAL PROSPECTIVE ANALYSIS
21. MP35-10 LONG TERM FOLLOW UP AND RISK OF HIGH-GRADE RECURRENCE IN LOW-GRADE PTA BLADDER CANCER PATIENTS
22. MP16-06 THE INTERNATIONAL BLADDER CANCER GROUP INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER (IBCG IR-NMIBC) SCORING SYSTEM PREDICTS THE NEED FOR INTERVENTION FOR PATIENTS ON ACTIVE SURVEILLANCE
23. MP74-08 [68GA]PSMA PET/CT VS. MPMRI IN PATIENTS WITH SUSPICION OF PROSTATE CANCER AND PREVIOUS NEGATIVE BIOPSY: RESULTS OF THE PROSPET-BX TRIAL
24. Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy
25. Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report
26. A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies
27. The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature.
28. Nutritional Prehabilitation in Patients Undergoing Cystectomy: A Systematic Review.
29. Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy.
30. Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection
31. Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center.
32. The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma
33. Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?
34. Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C (MMC) treatment in patients with primary treatment-naïve vesical neoplasms: Interim analysis.
35. Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
36. Imaging predictive biomarkers of response in patients with prostate cancer undergoing high-intensity focused ultrasound (HIFU) focal therapy.
37. Assessing the mid-term impact of enhanced prostate cancer screening in Caucasian men with germline DNA repair pathogenic variants.
38. Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor
39. Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508–515
40. Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508–15
41. Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration
42. Robotic assisted vs open radical cystectomy: an updated systematic review and meta-analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.